These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 10711322

  • 1. The effect of a closed formulary on prescription drug use and costs.
    Motheral BR, Henderson R.
    Inquiry; ; 36(4):481-91. PubMed ID: 10711322
    [Abstract] [Full Text] [Related]

  • 2. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation.
    Motheral BR, Henderson R.
    Am J Manag Care; 1999 Nov; 5(11):1383-94. PubMed ID: 10662412
    [Abstract] [Full Text] [Related]

  • 3. Controlling prescription drug expenditures: a report of success.
    Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA.
    Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828
    [Abstract] [Full Text] [Related]

  • 4. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG.
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [Abstract] [Full Text] [Related]

  • 5. The effect of incentive-based formularies on prescription-drug utilization and spending.
    Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.
    N Engl J Med; 2003 Dec 04; 349(23):2224-32. PubMed ID: 14657430
    [Abstract] [Full Text] [Related]

  • 6. The effects of copayments and generic substitution on the use and costs of prescription drugs.
    Smith DG.
    Inquiry; 1993 Dec 04; 30(2):189-98. PubMed ID: 8314607
    [Abstract] [Full Text] [Related]

  • 7. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.
    J Drugs Dermatol; 2008 Jan 04; 7(1):41-9. PubMed ID: 18246697
    [Abstract] [Full Text] [Related]

  • 8. Managing prescription drug costs.
    Sica JM.
    Empl Benefits J; 2001 Mar 04; 26(1):35-40. PubMed ID: 11272515
    [Abstract] [Full Text] [Related]

  • 9. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
    Anderson GM, Kerluke KJ, Pulcins IR, Hertzman C, Barer ML.
    Inquiry; 1993 Mar 04; 30(2):199-207. PubMed ID: 8314608
    [Abstract] [Full Text] [Related]

  • 10. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC.
    EBRI Issue Brief; 2004 Jan 04; (265):1-35. PubMed ID: 14969223
    [No Abstract] [Full Text] [Related]

  • 11. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W, Wangsaturaka D, Nantawan P, Itthipanichapong C, Thamaree S, Wittayalertpanya S, Ketcharoen A, Taworn N, Kemsri W, Kusolsomboon T, Tangphao O.
    J Med Assoc Thai; 2002 Jun 04; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [Abstract] [Full Text] [Related]

  • 12. Expenditures for prescription drugs: too much or not enough?
    Schumock GT, Walton SM.
    Healthc Financ Manage; 2003 Oct 04; 57(10):34-8, 41. PubMed ID: 14560578
    [Abstract] [Full Text] [Related]

  • 13. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C.
    EBRI Issue Brief; 1999 Apr 04; (208):1-21. PubMed ID: 10539445
    [Abstract] [Full Text] [Related]

  • 14. The effect of a three-tier formulary on antidepressant utilization and expenditures.
    Hodgkin D, Parks Thomas C, Simoni-Wastila L, Ritter GA, Lee S.
    J Ment Health Policy Econ; 2008 Jun 04; 11(2):67-77. PubMed ID: 18509214
    [Abstract] [Full Text] [Related]

  • 15. Do consumers' attitudes predict prescription purchasing behavior?
    Nair KV.
    Manag Care Interface; 2003 Jun 04; 16(6):22-7, 55. PubMed ID: 12841073
    [Abstract] [Full Text] [Related]

  • 16. Incentive formularies and changes in prescription drug spending.
    Landon BE, Rosenthal MB, Normand SL, Spettell C, Lessler A, Underwood HR, Newhouse JP.
    Am J Manag Care; 2007 Jun 04; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [Abstract] [Full Text] [Related]

  • 17. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
    Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S.
    Arthritis Res Ther; 2005 Jun 04; 7(2):R333-42. PubMed ID: 15743481
    [Abstract] [Full Text] [Related]

  • 18. Prescription drug trend begins showing modest slowdown.
    Capitation Rates Data; 2002 Jul 04; 7(7):76-80. PubMed ID: 12164063
    [No Abstract] [Full Text] [Related]

  • 19. Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors.
    Wang YR, Pauly MV.
    Manag Care Interface; 2005 Aug 04; 18(8):39-45. PubMed ID: 16127891
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.